This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act and section 4.2.4 of Euronext Oslo Rulebook II.

The mandatory labeling information includes a patient decision checklist that highlights key information about risks; warning information formatted in a box to make it noticeable; and a patient ...

This article delves into the key aspects of the upcoming legislation, providing a comprehensive guide to what these changes entail and how they might affect you. Several factors have driven the ...